Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 22 July 2020, 04:00 HKT/SGT
Share:

Source: The Scheer Foundation
Madeline 'Maddy' Cross-Parkin Appointed Director of Music Grants for The Scheer Foundation

Beverly Hills, CA and Brisbane, AU, July 22, 2020 - (ACN Newswire) - The Scheer Foundation announced today the appointment of Ms. Madeline "Maddy" Cross-Parkin as Director of Music Grants, effective July 14, 2020.


Maddy, who was chosen after an international search, is a brilliant pianist currently following a cursus at the University of Queensland in Brisbane, Australia. Maddy will lead the Music Grants allocation of the Foundation, and will develop a strategic plan for the Foundation music initiatives. Maddy will have the ultimate decision in granting assistance to young artists.

The Scheer Foundation historically has been operated in the fight against malnutrition but has recently expanded its reach to Arts & Music. The Scheer Foundation is committed to serving the fields of classical music in supporting promising young artists.

"The world of music is international and does not know borders. Music bring peace and joy around the world and therefore we have decided to dedicate some of our efforts to Music," said Frederic Scheer, Chairman of the Foundation.

"Maddy is young, a brilliant artist and her energy and dedication will bring joy to a lot of people. I salute her willingness to participate in this new adventure. It is rare to see young people volunteering for helping others, we are privileged and happy to welcome her."

About the Scheer Foundation

The Frederic & Jocelyne Scheer Foundation is a US Private Foundation (501-c 3) dedicated to fighting malnutrition and children mortality in Africa and promoting local agricultural and industrial project to build up local and regional employment. The Foundation recently expanded its reach to Arts & Music.

Learn more at www.scheerfoundation.info.

Contact: info@scheerfoundation.org
or: Maddy@scheerfoundation.org
Tel: +1 310 525 9037



Topic: Press release summary
Source: The Scheer Foundation

Sectors: Education
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Philippine Airlines' Flash Sale Offers Up to 40% Off Base Fares Until July 17 Only  
July 17, 2026 13:48 HKT/SGT
Riyadh Emerges as a Global Powerhouse as Blockchain Infrastructure & AI Take Center Stage at Global Blockchain Show 2026  
July 17, 2026 12:58 HKT/SGT
AI-Driven LiveOps and Mobile Dominance Take Center Stage at Global Games Show Riyadh 2026  
July 17, 2026 12:14 HKT/SGT
JCB Celebrates 30 Years of Trust, Honoring 70 Years of Japan-Philippines Friendship  
Friday, July 17, 2026 9:00:00 AM
CTF Life Becomes First Insurer to Forge Long-term Strategic Partnership with Tencent Music Entertainment Group to Debut TIMA in Hong Kong This August  
July 17, 2026 08:27 HKT/SGT
TANAKA Commences Operation of "TANAKA H2 Nexus", One of Japan's Largest 500 kW Pure Hydrogen Fuel Cell Power Generation Facilities  
Thursday, July 16, 2026 9:00:00 PM
Community Creates Mega Artwork for HKTDC 60th Anniversary  
July 16, 2026 19:15 HKT/SGT
Cornerstone Robotics to Present at the 2nd Global Health Summit (GHS 2026)  
July 16, 2026 14:07 HKT/SGT
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment  
Wednesday, July 15, 2026 11:18:00 PM
FDA Approves LEQEMBI IQLIK(R) (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease  
Wednesday, July 15, 2026 10:51:00 PM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: